<DOC>
<DOCNO>
EP-0000113
</DOCNO>
<TEXT>
<DATE>
19790110
</DATE>
<IPC-CLASSIFICATIONS>
A61K-31/50 C07D-237/00 <main>C07D-237/04</main> C07D-237/04 A61P-7/00 A61P-9/00 A61P-9/12 A61P-7/02 
</IPC-CLASSIFICATIONS>
<TITLE>
dihydropyridazones, their preparation and medicines containing them and dihydropyridazones for use in medical treatments.
</TITLE>
<APPLICANT>
basf agde<sep>basf aktiengesellschaft<sep>basf aktiengesellschaftcarl-bosch-strasse 3867063 ludwigshafende <sep>basf aktiengesellschaft<sep>
</APPLICANT>
<INVENTOR>
gries josef dr <sep>koenig horst dr <sep>kunze johannes dr<sep>lebkuecher rolf dr<sep>lehmann hans dieter dr<sep>lenke dieter dr<sep>thyes marco dr<sep>gries, josef, dr.<sep>koenig, horst, dr.<sep>kunze, johannes, dr.<sep>lebkuecher, rolf, dr.<sep>lehmann, hans dieter, dr.<sep>lenke, dieter, dr.<sep>thyes, marco, dr.<sep>gries, josef, dr.roemerweg 43d-6706 wachenheimde<sep>koenig, horst, dr.pariser strasse 4d-6700 ludwigshafende<sep>kunze, johannes, dr.hoferweg 4d-8350 plattlingde<sep>lebkuecher, rolf, dr.kranichstrasse 9d-6700 ludwigshafende<sep>lehmann, hans dieter, dr.im hefen 15d-6945 hirschberg-leuterhausende<sep>lenke, dieter, dr.kekuléplatz 1d-6700 ludwigshafende<sep>thyes, marco, dr.mundenheimer strasse 148d-6700 ludwigshafende<sep>gries, josef, dr.<sep>koenig, horst, dr.<sep>kunze, johannes, dr.<sep>lebkuecher, rolf, dr.<sep>lehmann, hans dieter, dr.<sep>lenke, dieter, dr.<sep>thyes, marco, dr.<sep>gries, josef, dr.roemerweg 43 d-6706 wachenheim de  <sep>koenig, horst, dr.pariser strasse 4d-6700 ludwigshafende<sep>kunze, johannes, dr.hoferweg 4d-8350 plattlingde<sep>lebkuecher, rolf, dr.kranichstrasse 9d-6700 ludwigshafende<sep>lehmann, hans dieter, dr.im hefen 15d-6945 hirschberg-leuterhausende<sep>lenke, dieter, dr.kekuléplatz 1d-6700 ludwigshafende<sep>thyes, marco, dr.mundenheimer strasse 148d-6700 ludwigshafende<sep>
</INVENTOR>
<ABSTRACT>
The invention relates to 6- (p-acylaminophenyl) -4,5-dihydropyridazone (3) of formula I in EER for R¹ is hydrogen or an alkyl radical having 1 to 3 C atoms and R² when a hydrogen atom is represents for R¹Through a halogen atom substituted alkyl radical with 3 to 6 C atoms or a β-haloethyl radical or when R¹ is an alkyl radical having 1 to 3 C atoms, a 1 to 6 C atoms substituted by a halogen atom, their preparation means their preparationand therapeutic agents having a compound of formula I as active ingredient, where R² also includes a halogenmethyl or halide ethyl radical in the case where R¹ is hydrogen.These compounds are suitable as anti-hypertensiva and for prophylaxis and therapy thrombo-embolic diseases.
</ABSTRACT>
</TEXT>
</DOC>
